Hypertension, dyslipidemia and overweight are related to lower testosterone levels in a cohort of men undergoing prostate biopsy

International Journal of Impotence Research

Volumn 24, Issue 3, 2012, Pages 110-113

  Garcia Cruz, E ^a   Piqueras, M ^a   Huguet, J ^a   Perez Marquez, M ^a   Gosalbez, D ^a   Peri, L ^a   Izquierdo, L ^a   Luque, P ^a   Ribal, M J ^a   Alcaraz, A ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

dyslipidemia; hypertension; overweight; prostate biopsy; testosterone

Indexed keywords

TESTOSTERONE;

AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; DISEASE ASSOCIATION; DYSLIPIDEMIA; HORMONE DETERMINATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE BIOPSY; SMOKING;

AGED; BIOPSY; CARDIOVASCULAR DISEASES; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; OVERWEIGHT; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TESTOSTERONE;

EID: 84861234076     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/ijir.2011.55     Document Type: Article

References (22)

1. Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, et al. EMAS Group. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010; 363: 123-135.
2. Gray A, Feldman HA, McKinlay JB. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991; 73: 1016.
3. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2002; 87: 589-598. (Pubitemid 34158223)
4. Wang C, Nieschlag E, Swerdloff R. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol 2009; 55: 121.
5. Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol 2010; 57: 804-814.
6. Traish AM, Saad F, Feeley RJ, Guay A. The dark side of testosterone deficiency: III. Cardiovascular disease. J Androl 2009; 30: 477-494.
7. Traish AM, Saad F, Guay A. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. J Androl 2009; 30: 23-32.
8. Traish AM, Guay A, Feeley R, Saad F. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. J Androl 2009; 30: 10-22.
9. Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR. Low serum testosterone and mortality in male veterans. Arch Intern Med 2006; 166: 1660-1665. (Pubitemid 44232378)
10. Corona G, Monami M, Rastrelli G, Aversa A, Tishova Y, Saad F et al. Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med 2011; 8: 272-283.
11. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640-1645.
12. Basaria S. Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth. J Androl 2008; 29: 534-539.
13. Zitzmann M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol 2009; 5: 673-681.
14. Taskinen MR. Is metabolic syndrome the main threat to human health in the twenty-first century? Arterioscler Thromb Vasc Biol 2007; 27: 2275.
15. Mart́inez-Jabaloyas, Comorbidities in men with erectile dysfunction with and without hypogonadism. JMH 2010(7) 303-304.
16. Kaplan SA, Meehan AG, Shah A. The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men? J Urol 2006; 176: 1524-1528.
17. Pitteloud N, Mootha VK, Dwyer AA, Hardin M, Lee H, Eriksson KF et al. Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care 2005; 28: 1636-1642. (Pubitemid 41340902)
18. Pasquali R, Casimirri F, De Iasio R, Mesini P, Boschi S, Chierici R et al. Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. J Clin Endocrinol Metab 1995; 80: 654-658.
19. Isidori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V, Isidori A et al. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf) 2005; 63: 280-293. (Pubitemid 41233445)
20. Corona G, Mannucci E, Petrone L, Schulman C, Balercia G, Fisher AD et al. A comparison of NCEP- ATPIII and IDF metabolic syndrome definitions with relation to metabolic syndrome-associated sexual dysfunction. J Sex Med 2007a; 4: 789-796. (Pubitemid 46779316)
21. Hughes GS, Mathur RS, Margolius HS. Sex steroid hormones are altered in essential hypertension. J Hypertens 1989; 7: 181-187. (Pubitemid 19093890)
22. Labropoulos B, Velonakis E, Oekonomakos P, Laskaris J, Katsimades D. Serum sex hormones in patients with coronary disease and their relationship to known factors causing atherosclerosis. Cardiology 1982; 69: 98-103. (Pubitemid 12080435)